Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Annovis Bio, Inc. | anvs-20210630xex32d1.htm |
| EX-31.2 - EX-31.2 - Annovis Bio, Inc. | anvs-20210630xex31d2.htm |
| EX-31.1 - EX-31.1 - Annovis Bio, Inc. | anvs-20210630xex31d1.htm |
| 10-Q - 10-Q - Annovis Bio, Inc. | anvs-20210630x10q.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Annovis Bio, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jeffrey McGroarty, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: July 28, 2021 | /s/ Jeffrey McGroarty |
Jeffrey McGroarty | |
Chief Financial Officer |